134 related articles for article (PubMed ID: 3101766)
1. Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells.
Mason DY; Stein H; Gerdes J; Pulford KA; Ralfkiaer E; Falini B; Erber WN; Micklem K; Gatter KC
Blood; 1987 Mar; 69(3):836-40. PubMed ID: 3101766
[TBL] [Abstract][Full Text] [Related]
2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
3. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.
Campana D; Janossy G; Bofill M; Trejdosiewicz LK; Ma D; Hoffbrand AV; Mason DY; Lebacq AM; Forster HK
J Immunol; 1985 Mar; 134(3):1524-30. PubMed ID: 3918103
[TBL] [Abstract][Full Text] [Related]
4. Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues.
Knowles DM; Tolidjian B; Marboe CC; Mittler RS; Talle MA; Goldstein G
Blood; 1984 Apr; 63(4):886-96. PubMed ID: 6423012
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-B monoclonal antibodies (DBB.42, DBA.44, DNA.7, and DND.53) reactive on paraffin-embedded tissues with a new B-lymphoma cell line grafted into athymic nude mice.
al Saati T; Caspar S; Brousset P; Chittal S; Caverivière P; Hounieu H; Dastugue N; Idoipe JB; Icart J; Mazerolles C
Blood; 1989 Nov; 74(7):2476-85. PubMed ID: 2679917
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
8. The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies.
Falini B; Schwarting R; Erber W; Posnett DN; Martelli MF; Grignani F; Zuccaccia M; Gatter KC; Cernetti C; Stein H
Am J Clin Pathol; 1985 Mar; 83(3):289-300. PubMed ID: 3156489
[TBL] [Abstract][Full Text] [Related]
9. Membrane phenotypic studies in B cell lymphoproliferative disorders.
Scott CS; Limbert HJ; MacKarill ID; Roberts BE
J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
[TBL] [Abstract][Full Text] [Related]
10. The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis.
Miller ML; Fishleder AJ; Tubbs RR
Am J Clin Pathol; 1991 Jul; 96(1):100-8. PubMed ID: 2069128
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
12. The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies.
Li JL; Shen GL; Ghetie MA; May RD; Till M; Ghetie V; Uhr JW; Janossy G; Thorpe PE; Amlot P
Cell Immunol; 1989 Jan; 118(1):85-99. PubMed ID: 2463099
[TBL] [Abstract][Full Text] [Related]
13. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
15. A new human B-lymphocyte surface antigen (BL 2) detectable by a hybridoma monoclonal antibody: distribution on benign and malignant lymphoid cells.
Knowles DM; Tolidjian B; Marboe CC; Halper JP; Azzo W; Wang CY
Blood; 1983 Jul; 62(1):191-9. PubMed ID: 6190520
[TBL] [Abstract][Full Text] [Related]
16. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
[TBL] [Abstract][Full Text] [Related]
17. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies in the treatment of chronic lymphoid leukemias.
Robak T
Leuk Lymphoma; 2004 Feb; 45(2):205-19. PubMed ID: 15101704
[TBL] [Abstract][Full Text] [Related]
19. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
Moore K; Cooper SA; Jones DB
J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
[TBL] [Abstract][Full Text] [Related]
20. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
